It is our honor and pleasure to invite you to participate in the 19th MIXiii-BIOMED Conference and Exhibition, to be held May 12-14, 2020 in Tel Aviv, Israel.
Within the arena of health care, quality of life is viewed as multidimensional, encompassing emotional, physical, material, and social well-being. Human lifespan could soon pass 100 years thanks to medical science and technology. Artificial intelligence, machine learning, genomics and other technologies may lead to an extended life. In today’s modern society, there exists a “religious” fervor of prolonging life at a potential cost of reduced quality of life.
In the upcoming MIXiii-BIOMED 2020 conference we will focus our attention to this very important issue of “Quality of our extended lives – Pros and Cons”.
Robert Cohen
VP of Global R&D, Chief Technology Officer, Stryker Joint Replacement
Amy Schulman
Managing Partner, Polaris Partners
Prof. Robert Langer
Institute Professor at MIT, MIT Department of Chemical Engineering
Andrew “Cal” Callaway
Managing Director, U.S. Healthcare Investment Banking, Royal Bank of Canada (RBC)
Prof. Yitshak Kreiss, MD
Director General, Sheba Medical Center
Maurice R. Ferre, MD
CEO and Chairman of the Board, Insightec
Jeremy M. Levin MD
CEO and Chairman, Ovid Therapeutics
Eric H. Rubin MD
Senior VP, Global Clinical Oncology, Merck & Co
Aharon Aharon
CEO, Israel Innovation Authority (IIA)
The Israeli Biomed Unicorns
Amir Gross, Ex-CEO, Valtech
Ori Hadomi, Ex-CEO, Mazor Robotics
Prof. Raphael Beyar, MD, PhD, Co-Founder, Corindus
Oded S. Lieberman, PhD, MBA, Ex-CEO, NeuroDerm
Asaf Danziger, CEO, Novocure
Delos M. Cosgrove, MD
Executive Advisor to Google;
Former President & CEO, Cleveland Clinic
Targeted Cancer Treatment; Cure? Maintenance? – Has Medicine Reached these Points?
Chair: Prof. David Sidransky, MD,
Johns Hopkins School of Medicine; Co-Founder & General Partner, Israel Biotech Fund
Decoding the Brain Enigma: Parkinson, Alzheimer’s, ALS, Mental Disorders
Co-Chairs: Barry Greene
President, Alnylam Pharmaceuticals
Dekel Taliaz, PhD
Co-Founder and CEO, Taliaz
AI Technology Redefining the Future of Biopharma, Care Delivery, and Holistic Medicine
Co-Chairs: Iris Grossman, PhD
Chief Scientific Officer, Camp4 Therapeutics
Tamara Mansfeld
Global Innovation Lead, Digital Innovation Lab, Pfizer
Next Generation BioTherapeutics – Gene Editing, RNAi, Oligos, Cell and Gene Therapies and others
Co-Chairs: Yaron Carmi, PhD
Assistant Professor, Sackler School of Medicine, Tel Aviv University
Jonathan Solomon
CEO, BiomX
Bright Spots Illuminating the Future of Medical Devices
Co-chairs: Irit Yaniv, MD
Managing Partner, Accelmed Ventures Fund
James Eadie, MD
Partner, Santé Ventures
Exact and Biological Science Diagnostics – Sensors, Genomics, AI, Imaging, and others
Co-Chairs: Prof. Varda Shalev, MD, MPA
Head, KSM Kahn – Sagol – Maccabi Research & Innovation Institute
Yair Schindel, MD
Managing Partner & Co-Founder, aMoon Fund
Robotics Role in Future Healthcare Systems
Chair: Ori Hadomi
VP New Business Development & Partnerships, Medtronic
Aging Science and Technology – From Single Cell to Population at Large
Co-Chairs: Anat Naschitz
Managing Director, OrbiMed Advisors
Yael Benvenisti, PhD
CEO, Mediterranean Towers Ventures
Federico Goodsaid, PhD
Ex-FDA & Senior VP Regulatory Affairs, Ariana Pharma
Dimitris Agrafiotis, PhD
Chief Information Officer, Novartis Institutes for BioMedical Research (NIBR)
Rosana Kapeller-Libermann, PhD
EIR, Google Ventures
Daphna Laifenfeld, PhD
Chief Strategy Officer, Ibex Medical Analytics
Michal Ozery-Flato, PhD
Machine Learning Researcher, IBM Research
Eric de La Fortelle, PhD
Venture Partner, Seventure
Pierre Belichard
CEO, Enterome
Jeremy M. Levin MD
CEO and Chairman, Ovid Therapeutics
Andre Machado, MD, PhD
Neurological Institute, Chairman
Functional Neurosurgery, Endowed Chair,
Cleveland Clinic
Dimitrios Arkilo, MD
Sr. Medical Director, Global Clinical Lead. Takeda Pharmaceutical Co
Prof. Amir Lerman, MD
Cardiovascular Diseases and Internal Medicine, Mayo Clinic
Prof. Tamar Flash, PhD
Department of Computer Science and Applied Mathematics, Weizmann Institute of Science
Wenbo Liu
Sinovation (Beijing) Medical Technology Co., LTD
Allitia DiBernardo, MD
Global Medical Affairs Lead, Neurosciences, The Janssen Pharmaceutical Companies of Johnson & Johnson
Prof. Peter A. Noseworthy, MD
Department of Cardiovascular Medicine
Mayo Clinic
Miro Venturi, PhD
Global Head – Diagnostics Biomarkers
F. Hoffmann-La Roche Ltd.
Barry Greene
President, Alnylam Pharmaceuticals
Tom Sudow
Director Business Development, Cleveland Clinic Innovations
